The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 18, 2003

Filed:

Jun. 28, 1999
Applicant:
Inventors:

John W. Shiver, Doylestown, PA (US);

Mary Ellen Davies, Norristown, PA (US);

Daniel C. Freed, King of Prussia, PA (US);

Margaret A. Liu, Rosemont, PA (US);

Helen C. Perry, Lansdale, PA (US);

Assignee:

Merck & Co., Inc., Rahway, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/06 ; C12Q 1/70 ; C12P 2/104 ; A61K 3/921 ; C07H 2/104 ;
U.S. Cl.
CPC ...
C12N 5/06 ; C12Q 1/70 ; C12P 2/104 ; A61K 3/921 ; C07H 2/104 ;
Abstract

Synthetic polynucleotides comprising a DNA sequence encoding a peptide or protein are provided. The DNA sequence of the synthetic polynucleotides comprise codons optimized for expression in a nonhomologous host. The invention is exemplified by synthetic DNA molecules encoding HIV env as well as modifications of HIV env. The codons of the synthetic molecules include the projected host cell's preferred codons. The synthetic molecules provide preferred forms of foreign genetic material. The synthetic molecules may be used as a polynucleotide vaccine which provides immunoprophylaxis against HIV infection through neutralizing antibody and cell-mediated immunity. This invention provides polynucleotides which, when directly introduced into a vertebrate in vivo, including mammals such as primates and humans, induces the expression of encoded proteins within the animal.


Find Patent Forward Citations

Loading…